Occudo Quantitative Strategies LP Cerus Corp Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$3.43 - $5.83 $75,638 - $128,563
22,052 Added 37.45%
80,943 $291,000
Q2 2022

Aug 15, 2022
SELL
$4.41 - $5.69 $203,958 - $263,156
-46,249 Reduced 43.99%
58,891 $312,000
Q1 2022

May 16, 2022
BUY
$4.81 - $6.99 $240,557 - $349,583
50,012 Added 90.72%
105,140 $577,000
Q4 2021

Feb 14, 2022
SELL
$5.97 - $7.93 $25,020 - $33,234
-4,191 Reduced 7.07%
55,128 $375,000
Q3 2021

Nov 15, 2021
BUY
$4.79 - $6.68 $60,516 - $84,395
12,634 Added 27.06%
59,319 $361,000
Q2 2021

Aug 16, 2021
BUY
$5.35 - $6.35 $249,764 - $296,449
46,685 New
46,685 $276,000

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email